Merit Medical Systems, Inc. Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Million

Consolidate Quarterly Results

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Net Sales

394.18

384.26

381.95

354.33

354.57

339.14

337.58

Other Operating Income

0.00

Total Operating income

394.18

384.26

381.95

354.33

354.57

339.14

337.58

Raw Material Cost

198.74

197.75

197.73

182.80

181.16

182.56

177.26

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

Power Cost

0.00

Manufacturing Expenses

6.36

6.75

6.78

6.57

7.99

7.76

8.38

Selling and Distribution Expenses

114.83

119.80

113.10

98.29

107.97

99.64

94.58

Other Expenses

2.02

1.72

1.76

1.59

1.72

1.28

1.19

Total Expenditure (Excl Depreciation)

340.11

341.51

335.20

303.56

314.33

302.74

292.11

Operating Profit (PBDIT) excl Other Income

54.1

42.699999999999996

46.8

50.8

40.199999999999996

36.4

45.5

Other Income

3.69

3.31

2.20

4.14

1.60

10.24

8.41

Operating Profit (PBDIT)

92.09

80.30

82.76

87.18

73.43

76.02

80.91

Interest

6.36

6.75

6.78

6.57

7.99

7.76

8.38

Exceptional Items

-0.34

-0.76

1.20

-10.38

-0.69

-2.23

0.34

Gross Profit (PBDT)

195.45

186.52

184.22

171.53

173.40

156.57

160.32

Depreciation

34.33

34.24

33.80

32.28

31.60

29.38

27.03

Profit Before Tax

51.06

38.54

43.38

37.96

33.15

36.66

45.84

Tax

13.05

10.79

10.80

7.81

5.20

8.21

10.12

Provisions and contingencies

0.00

Profit After Tax

38.01

27.75

32.58

30.15

27.95

28.44

35.73

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

38.01

27.75

32.58

30.15

27.95

28.44

35.73

Share in Profit of Associates

0.00

Minority Interest

0.00

Other related items

0.00

Consolidated Net Profit

38.01

27.75

32.58

30.15

27.95

28.44

35.73

Equity Capital

0.00

Face Value

0.0

Reserves

1,584.30

1,529.41

1,488.05

1,428.42

1,379.36

1,323.41

1,282.44

Earnings per share (EPS)

0.63

0.46

0.54

0.49

0.46

0.48

0.61

Diluted Earnings per share

0.63

0.46

0.54

0.49

0.46

0.48

0.61

Operating Profit Margin (Excl OI)

13.72%

11.13%

12.24%

14.33%

11.35%

10.73%

13.47%

Gross Profit Margin

21.66%

18.94%

20.21%

19.82%

18.26%

19.47%

21.59%

PAT Margin

9.64%

7.22%

8.53%

8.51%

7.88%

8.39%

10.58%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Dec 2025 is 2.58% vs 0.60% in Sep 2025

Consolidate Net Profit

QoQ Growth in quarter ended Dec 2025 is 36.69% vs -14.72% in Sep 2025

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is 14.81% vs -4.47% in Sep 2025

Interest

QoQ Growth in quarter ended Dec 2025 is -5.88% vs 0.00% in Sep 2025

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

Compare Quarterly Results Of Merit Medical Systems, Inc. With

Select Peers

Figures in Million

Consolidate Quarterly Results

Change(USD)

Change(%)

Net Sales

394.18

303.44

90.74

29.90%

Other Operating Income

0.00

Total Operating income

394.18

303.44

90.74

29.90%

Raw Material Cost

198.74

140.54

58.20

41.41%

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

Power Cost

0.00

Manufacturing Expenses

6.36

33.47

-27.11

-81.00%

Selling and Distribution Expenses

114.83

48.31

66.52

137.69%

Other Expenses

2.02

-3.35

5.37

160.30%

Total Expenditure (Excl Depreciation)

340.11

188.86

151.25

80.09%

Operating Profit (PBDIT) excl Other Income

54.08

114.59

-60.51

-52.81%

Other Income

3.69

-1.47

5.16

351.02%

Operating Profit (PBDIT)

92.09

146.15

-54.06

-36.99%

Interest

6.36

33.47

-27.11

-81.00%

Exceptional Items

-0.34

-9.15

8.81

96.28%

Gross Profit (PBDT)

195.45

162.90

32.55

19.98%

Depreciation

34.33

33.04

1.29

3.90%

Profit Before Tax

51.06

70.50

-19.44

-27.57%

Tax

13.05

35.65

-22.60

-63.39%

Provisions and contingencies

0.00

Profit After Tax

38.01

34.85

3.16

9.07%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

38.01

34.85

3.16

9.07%

Share in Profit of Associates

0.00

Minority Interest

0.00

Other related items

0.00

Consolidated Net Profit

38.01

34.85

3.16

9.07%

Equity Capital

0.00

Face Value

0.00

0.01

0.00

Reserves

1,584.30

606.03

978.27

161.42%

Earnings per share (EPS)

0.63

0.12

0.51

425.00%

Diluted Earnings per share

0.63

0.12

0.51

425.00%

Operating Profit Margin (Excl OI)

13.72%

37.76%

0.00

-24.04%

Gross Profit Margin

21.66%

34.12%

0.00

-12.46%

PAT Margin

9.64%

11.48%

0.00

-1.84%

Public Share Holdings (%)

0.00

0.00%

Pledged Promotor Holding (%)

0.00

0.00%

Quarterly - Net Sales

Net Sales 39.42 Million

in Dec 2025

Figures in Million

QoQ Growth in quarter ended Dec 2025 is 2.58% vs 0.60% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 11.17% vs 9.68% in Dec 2024

Quarterly - Consolidate Net Profit

Consolidate Net Profit 3.80 Million

in Dec 2025

Figures in Million

QoQ Growth in quarter ended Dec 2025 is 36.69% vs -14.72% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 36.20% vs 1.09% in Dec 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 8.84 Million

in Dec 2025

Figures in Million

QoQ Growth in quarter ended Dec 2025 is 14.81% vs -4.47% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 23.12% vs 21.49% in Dec 2024

Quarterly - Interest

Interest 0.64 Million

in Dec 2025

Figures in Million

QoQ Growth in quarter ended Dec 2025 is -5.88% vs 0.00% in Sep 2025

YoY Growth in quarter ended Dec 2025 is -20.00% vs 40.35% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 13.72%

in Dec 2025

Figures in %

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024